← Back to companies
~£15B Annual net revenue (2024)
$2.5M+ U.S. federal lobbying 2024 (OpenSecrets)
40+ Brands in portfolio (Reckitt)
Filter:
2025

Reckitt lobbying on disinfectants, infant formula, and OTC drugs

Reckitt reported federal lobbying on EPA disinfectant regulations, FDA infant formula and OTC drug oversight, and consumer product safety. The company engages on issues affecting Lysol, Enfamil, Mucinex, and other health and hygiene brands. Disclosures were reported via OpenSecrets and Senate lobbying databases.

Political